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Abstract
Development of treatments for acute and chronic pain conditions remains a challenge, with an unmet need for improved
sensitivity and reproducibility in measuring pain in patients. Here we used pulsed-continuous arterial spin-labelling [pCASL],
a relatively novel perfusion magnetic-resonance imaging technique, in conjunction with a commonly-used post-surgical
model, to measure changes in regional cerebral blood flow [rCBF] associated with the experience of being in ongoing pain.
We demonstrate repeatable, reproducible assessment of ongoing pain that is independent of patient self-report. In a cross-
over trial design, 16 participants requiring bilateral removal of lower-jaw third molars underwent pain-free pre-surgical
pCASL scans. Following extraction of either left or right tooth, repeat scans were acquired during post-operative ongoing
pain. When pain-free following surgical recovery, the pre/post-surgical scanning procedure was repeated for the remaining
tooth. Voxelwise statistical comparison of pre and post-surgical scans was performed to reveal rCBF changes representing
ongoing pain. In addition, rCBF values in predefined pain and control brain regions were obtained. rCBF increases (5–10%)
representing post-surgical ongoing pain were identified bilaterally in a network including primary and secondary
somatosensory, insula and cingulate cortices, thalamus, amygdala, hippocampus, midbrain and brainstem (including
trigeminal ganglion and principal-sensory nucleus), but not in a control region in visual cortex. rCBF changes were
reproducible, with no rCBF differences identified across scans within-session or between post-surgical pain sessions. This is
the first report of the cerebral representation of ongoing post-surgical pain without the need for exogenous tracers. Regions
of rCBF increases are plausibly associated with pain and the technique is reproducible, providing an attractive proposition
for testing interventions for on-going pain that do not rely solely on patient self-report. Our findings have the potential to
improve our understanding of the cerebral representation of persistent painful conditions, leading to improved
identification of specific patient sub-types and implementation of mechanism-based treatments.
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Introduction
As many as 80% of individuals experience moderate to severe
post-operative pain[1] and intractable pain in patients with cancer,
diabetes and HIV is a major healthcare concern[2]. The breadth
of available treatments for pain control remains limited with an
over-reliance on opiate-based medication[3]. Without a record-
able biological marker for pain, decades of analgesic trials have
relied largely on patients’ own reports to describe location,
intensity and quality of their pain. Standardised psychometric
techniques have been developed, but inter-individual variability in
pain reporting has often been incorrectly viewed as artefactual[4],
rather than representing true differences in pain experience.
According to a bio-psychosocial interpretation of pain[5],
individual differences in pain response are likely to include effects
of concurrent pathophysiology, cognitive and affective strategies
and confounding effects of co-medications[6]. Compounded by a
failure to report null findings, the search for novel analgesics
remains slow and expensive. It has been suggested that
performance issues inherent in traditional analgesic development
have been stymied by continuing to use the ‘‘evaluation tools and
infrastructure of the last century to develop this century’s drug
therapy’’[3]. With this in mind, novel indices for measuring pain
are required; ideally they should relate to an underlying aspect of
pain transduction, take account of bio-psycho-social factors and
translate between human and preclinical studies[6].
Modern neuroimaging techniques, such as Positron Emission
Tomography (PET) and functional Magnetic Resonance Imaging
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(fMRI), show great promise in the development of novel
measurement techniques, allowing non-invasive investigation of
the cerebral mechanisms underpinning the pain experience. Many
imaging studies to date, however, have relied on ‘experimental
pain’ models using healthy volunteers to derive brain responses to
acute, repeated, short-duration nociceptive stimuli (reviewed
in[7,8]). For ethical reasons, human experimental pain paradigms
are often expressly designed to provide a highly controllable,
psychophysically constrained stimulus that minimises tissue
damage. As a result, brain responses to such stimuli are highly
unlikely to account for the physiological changes that result from
tissue trauma[9]. In addition, neurological sequelae that relate
uniquely to individual chronic pain conditions[10,11,12] are
largely impossible to represent in experimental models of pain in
healthy controls; a fact reflected in the increasing reports of
neuroimaging investigations in patients with persistent pain[13].
Both post-traumatic pain and chronic painful conditions are
perceived as having an ongoing painful component. By contrast,
the majority of pain-imaging studies have relied on the statistical
comparison of a repeated nociceptive event with interspersed ‘rest’
or ‘control’ states derived within the same experimental session. As
a result, many of these studies to date have been ill-suited to
investigation of ongoing pain that cannot be modulated under
experimental control within-session[14].
Compared to studies examining responses to evoked pain, there
are relatively few neuroimaging reports describing the cerebral
representation of ongoing pain; fewer still describe clinical ongoing
pain. There are several reports using PET, for example
[15,16,17,18,19] but rather than examining the ongoing clinical
pain per se, several of these studies have examined CBF changes in
response to an experimentally-derived nociceptive stimulus in
addition to any ongoing background pain. Further, safety
considerations, availability, expense, small group sizes and inferior
temporal and spatial resolution (compared to fMRI), have limited
the impact of their findings. Similarly, reports using Blood
Oxygenation Level Dependent [BOLD] fMRI, for exam-
ple[20,21], have examined the relationship between changes in
participants’ self-reported pain and BOLD signal intensity, rather
than examination of the BOLD signal alone, producing results
confounded by motor responses underpinning participants’
continuous online pain ratings. Others have used BOLD fMRI
to examine inter-relationships in resting-state BOLD signal time
series information between brain regions, known as functional
connectivity analysis[22,23]. Perhaps most importantly, conven-
tional BOLD-fMRI paradigms are most sensitive to signal changes
over several seconds and are less suitable for examining pain
responses lasting many minutes[24] or for monitoring long-term
treatment effects[25]. By contrast, perfusion MRI methodologies
such as arterial spin labelling (ASL)[26,27] may be preferable for
the study of behaviours or states over the course of minutes as
opposed to seconds. ASL has already been documented as an ideal
methodology for the central investigation of ongoing, non-
paroxysmal pain[14]. The methodology provides quantitative,
reproducible rCBF measurements throughout the brain and has
superior noise-power characteristics, compared to fMRI, in
within-subject designs with a task periodicity of 120 seconds or
greater[28]. The application of ASL to the study of pain remains
in its infancy[29,30]; to the best of our knowledge there has yet to
be a report of the application of ASL to ongoing, clinically-
relevant pain.
Here we assess the validity of pulsed-continuous ASL [pCASL]
[31] as a quantitative, reproducible marker of ongoing post-
surgical pain. We applied the most commonly employed clinical
pain model used in trials of analgesics such as non-steroidal anti-
inflammatory drugs and opiates, the third molar extraction (TME)
model[32,33]. In the TME model, healthy participants, with no
prior history of chronic painful disease other than recurrent,
intermittent pericoronitis of their third molars, are recruited. As a
result, participants are unaffected by confounding variables such as
heterogeneity in pain distribution, concomitant medication and
pathology and participants can be initially assessed while
asymptomatic and completely pain-free. Often bilateral, similar-
ly-positioned wisdom teeth require extraction that are matched for
surgical difficulty, resulting in reproducible amounts of moderate-
to-severe post-surgical pain following each unilateral extrac-
tion[34]. Reproducibility of pain response renders the model ideal
for ‘cross-over’ placebo-controlled analgesic trials. In addition a
recent meta-analysis reported that TME-derived assessments of
analgesic efficacy could be extrapolated to other forms of post-
surgical pain[32], demonstrating the broad utility of the model.
In this study we applied pCASL to the challenge of representing
the cerebral basis of ongoing pain. We imposed three constraints,
namely that the ongoing pain experience was induced by genuine
tissue damage, could not be modulated by the experimenter within
a single session, and that assessments of ongoing pain could be
repeated to fulfil the requirements of a cross-over trial design. We
demonstrate quantitative, reproducible rCBF increases that
represent the experience of being in ongoing pain following
TME including those in a network of brain regions specified a
priori. Further, we provide novel insights into the central
representation of post-surgical trigeminal pain in humans. Our
findings are discussed in terms of their potential impact on
development of novel interventions for treatment of acute and
chronic pain conditions and how the pCASL technique might be
utilised in translational research.
Methods
Ethics Statement
This study was approved by Kings College Hospital Research
Ethics Committee (REC Reference 07/H0808/115).
Subjects and Materials
16 right-handed, healthy male volunteers aged 20–41,
(mean=26.4 years) provided informed consent to participate in
the study. Females were excluded due to potential variability in the
phase of the menstrual cycle affecting reproducibility of the
response to post-surgical pain[35]. All participants presented with
bilateral recurrent pericoronitis and fulfilled NICE guidelines for
extraction of lower-jaw left and right third molars[36].
Experimental Design
Participants were scanned on five separate occasions (S1–S5);
screening/familiarisation (S1), pre-surgical (S2) and post-surgical
sessions (S3) for the first extraction and pre-surgical (S4) and post-
surgical (S5) sessions for the second extraction. An interval of at
least two weeks separated S3 and S4, following complete recovery
from the first surgery. Order of left and right tooth extraction was
balanced and pseudo-randomised across the group. At each
session, pulse rate and blood pressure were recorded, an alcohol
and drug-screen performed and a psychometric assessment
completed. Analgesic medication (1000 mg paracetamol &
400 mg ibuprofen) was provided to participants immediately
following scanning during S3 & S5.
Procedure
At S1, standardised screening questionnaires were administered
to assess presence of any pain and baseline psychometric
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information (see Baseline Psychometry). A short MR examination
was performed for familiarisation with the imaging environment
and participants received training on using a computerised,
joystick-operated visual analogue scale (VAS). MR examinations
during sessions S2–S6 were identical, each comprised of six
separate consecutive pCASL scans, each lasting six minutes.
Participants were instructed to lie still with their eyes open. Prior to
and following acquisition of each rCBF map, participants
subjectively rated pain intensity and alertness using a computerised
VAS.
Baseline Psychometry
Baseline psychometric screening assessments were performed
for all participants prior to scanning at S1. Screening for
depression was performed using the Center for Epidemiological
Studies Depression Scale [CES-D][37], and trait and state anxiety
using the State-Trait Anxiety Questionnaire [STAQ][38]. Chang-
es in state anxiety relating to surgery were assessed at the
beginning of each session. Screening for general mental health
status was assessed using the Revised Symptom Checklist 90
[SCL-90-R][39], and for alcohol and drug abuse using sections 11
and 12 of the Schedules for Clinical Assessment in Neuropsychi-
atry [SCAN][40]. Finally, the Cognitive Coping Strategies
Inventory [CCSI][41] was administered in order to assess
participant coping strategies for pain. Participants with psycho-
metric data outside published normative limits for each test were
not included in the study.
Surgery
Unilateral TME was performed under local anaesthesia (4.4 ml
Lignospan Special, Septodont) using a standardized technique.
Surgical difficulty was rated on a 1-5 scale[42]. Following surgery,
participants were supervised for up to six hours before their post-
surgical scan, during which time ratings of pain intensity were
recorded using a pen-and-paper 100 mm VAS. Scanning
commenced when three consecutive VAS scores greater than
30/100 mm were provided within a 30-minute period.
Imaging Procedure
Imaging was performed on a 3 Tesla Signa HDx whole-body
MR imaging system (General Electric, USA) fitted with an 8-
channel, phased-array receive-only head coil. High-resolution T1-
and T2-weighted MR structural sequences were acquired for
radiological assessment and image registration. Resting-state rCBF
measurements were made using pCASL[31], using an irradiation
time of 1.5 s and post-labelling delay of 1.5 s. pCASL images were
acquired using a single-shot, Fast Spin Echo readout resulting in
whole-brain blood flow maps, with a spatial resolution of
16163 mm.
Image Preprocessing
Preprocessing and analysis were performed using FSL v4.1.0
[http://www.fmrib.ox.ac.uk/fsl][43]. Preprocessing prior to vox-
elwise analysis using a General Linear Model (GLM), consisted of
skull stripping [BET], registration to the Montreal Neurological
Institute (MNI) template [FLIRT] and a non-linear noise-
reduction algorithm [SUSAN] to improve signal-to-noise ratio
and condition the data for statistical analysis.
Surgical and Behavioural data analysis
All surgical and behavioural data analyses were computed using
GenStat v11.1 (http://www.vsni.co.uk/). Variability in perceived
surgical difficulty and surgery-to-scan time between left and right
tooth extractions were assessed using student’s t-tests. VAS
estimates of pain and alertness were fitted to a mixed effect
model, with Participant and Participant-by-Session as random
effects, and Session-pair (Pair 1[S2,S3]/Pair 2[S4,S5]), Surgery
(Pre-surgery/Left/Right tooth post-surgery),Timepoint, and Sur-
gery by Timepoint as fixed effects. A first-order auto-regressive
(AR(1)) covariance structure was specified for the repeated
measures Timepoint. Significance thresholds for all behavioural
analyses were at the p,0.05 level.
Whole brain voxel-wise analysis
Statistical analysis of pCASL data was applied at two levels
using a voxelwise optimised GLM [FLAMEO]. First-level analyses
were computed for each subject to create grey-matter only mean
and variance images of the six individual pCASL scans acquired at
each of sessions S2–S6. These images were used in a higher-level
mixed effects analysis with Participant, Surgery (Presurgery/Left/
Right tooth surgery) and Session-pair (Pair 1[S2,S3]/Pair
2[S4,S5]) as model terms, to assess changes in rCBF relating to
post-surgical pain and rCBF differences following left, compared
to right TME. Z-statistic images were thresholded using clusters
determined by Z.2.3 and a corrected cluster-significance
threshold of p = 0.05 according to random field theory[44].
ROI Creation
Anatomical ROIs in MNI-template space were derived from
Harvard-Oxford Cortical/Subcortical and Juelich-Histological
Atlases. Based on a priori information regarding brain activation
related to pain, ROIs were created for anterior cingulate cortex
[ACC], primary [S1], and secondary [SII] somatosensory cortices,
insula [INS], thalamus [THAL], amygdala [AMY] and hippo-
campus [HIP] in each cerebral hemisphere. Finally, an ROI was
created for V5/MT, an a priori-defined, comparably-sized control
ROI involved in visual motion perception and eye move-
ments[45]. We hypothesised that rCBF in V5/MT would not be
modulated by post-surgical pain.
ROI Data Extraction
Two ROI datasets were created. In both datasets, the mean of
the 20% voxels with greatest CBF values was computed[46] as a
summary measure. In set one, ROIs were extracted from each
individual CBF map acquired at for each participant at each
session; these data were used to examine temporal variation in
rCBF response to post-surgical pain. In set two, ROIs for each
hemisphere at each session were extracted from mean images
created following first level voxelwise analyses.
ROI Analysis
All ROI analyses were performed using GenStat v11.1.
Temporal variation within-session rCBF values extracted from set
one were plotted to examine temporal variation in rCBF value
within a single session. For each ROI in each hemisphere, rCBF
estimates from each pCASL scan were fitted to a mixed effect
model, with Participant, Participant-by-Session, Participant-by-
Session-by-Time and Participant-by-Session-by-Hemisphere as
random effects, Session-Pair (Pair 1/Pair 2) as fixed effect, and a
3-way factorial of Surgery (Pre-surgery/Left/Right tooth Post-
surgery) Hemiphere (Left/Right) and Timepoint (1–6). P-values
were Bonferroni corrected for multiple comparisons.
Pre/Post-surgical differences
For each ROI in each hemisphere, rCBF values for each subject
in each session were fitted to a mixed effect model. Participant and
Perfusion MRI Demonstrates Ongoing Pain
PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e17096
Participant-by-Session were fitted as random effects, and Surgery
(Pre-surgery/Left/Right-tooth post-surgery), Session-pair (Pair
1[S2,S3]/Pair 2[S4,S5]) and Hemisphere (Left/Right) were fitted
as fixed effects. Significance thresholds were imposed after
Bonferroni correction.
Correlation Analysis
For each ROI, an ANCOVA model was fitted to rCBF values
obtained from each hemisphere in set two. Subject was fitted as a
fixed effect and VAS estimate of pain [VAS] fitted as a covariate.
The model was used to calculate intra-subject correlation co-
efficients (rw) for each ROI[47]. Due to the exploratory nature of
these correlation analyses, multiple comparison correction was not
employed.
Results
Surgical Outcome
There were no differences relating to site of surgery (left versus
right). Perceived surgical difficulty and time taken from local
anaesthesia to first CBF map did not differ between left and right
surgeries (Difficulty: Left = 3.29, Right = 3.47; paired-t, p = 0.44;
Time taken: Left = 210 minutes, Right = 204 minutes; paired-t,
p = 0.738).
Psychometric Outcomes
Mean alertness ratings did not differ between pre- and post-
surgical MRIs (Pre-surgery = 62.36, Post-surgery = 66.4; p = 0.35),
(Figure 1a). There was no session order effect (p = 0.592). Mean
post-surgical pain ratings were increased compared to pre-surgical
visits (Figure 1b) (Pre-surgery = 1.8, Post-surgery = 56.5; F[1,39.6] =
432.99, p,0.001), but there were no differences following
extraction of left, compared to right, third molars (p = 0.97).
There was no session order effect (p = 0.55).
Neuroimaging
A distributed network of brain regions demonstrated significant
increases in rCBF relating to pain following extraction of left and
right third molars, compared to pain-free pre-surgical periods in
the same subjects. Table 1 details each cluster in brain regions we
hypothesised a priori would demonstrate CBF changes during post-
surgical pain; for brevity, only clusters with highest Z-scores per
Figure 1. Within-scanner time courses of VAS indices of (a) perceived alertness and (b) pain experienced pre/post each pCASL scan.
Each visit is plotted separately (Left tooth = Grey, Right Tooth = White; Filled circles = Post-surgical visit, Unfilled circles = Pre-surgical visit; Error
bars indicate 61 Standard Deviation.
doi:10.1371/journal.pone.0017096.g001
Table 1. Regions of increased post-surgical CBF specified a priori to underpin cerebral processing of pain.
Structure Left Hemisphere Right Hemisphere
Z-stat x y z Z-stat x y z
Primary Somatosensory Cortex 3.41 262 216 42 3.17 42 216 42
Secondary Somatosensory Cortex 3.29 256 214 14 3.36 54 214 16
Thalamus 3.46 220 228 16 3.76 16 236 6
Posterior Cingulate 3.02 28 264 12 3.38 24 270 6
Cingulate Gyrus 3.03 24 232 24 3.25 10 242 26
Mid-anterior Cingulate Gyrus 3.26 212 6 36 3.38 14 212 44
Anterior Cingulate - - - - 3.13 6 36 6
Hippocampus/Parahippocampus 4.05 228 250 26 4 26 244 24
Amygdala 3.8 230 2 226 4.32 24 0 214
Insula 3.47 244 210 6 4.1 40 212 14
doi:10.1371/journal.pone.0017096.t001
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anatomical region have been reported. We did not observe any
post-surgical decreases in CBF in these regions or elsewhere. In
particular, bilateral increases in rCBF during post-surgical pain
were identified in postcentral gyrus, specifically the somatotopic
region of S1 relating to the face/jaw[48,49] (Figure 2; 3a), in SII
(Figure 3b), extending ventrally towards posterior insula cortex
and in mid/anterior insula cortices, extending towards the frontal
operculum. At midline, clusters were observed bilaterally in mid-
anterior cingulate cortices, (Figure 3c) extending towards perigen-
ual cingulate cortex, and in posterior cingulate gyrus close to the
splenium of the corpus callosum. In the temporal lobe, clusters
were identified in amygdala (Figure 3d), extending dorsally
through hippocampal/parahippocampal cortices (Figure 3e). In
the thalamus, a single, bilateral interconnected cluster was
identified which included pulvinar, ventral posterior, ventromedial
and anterior regions at midline, extending inferiorly to include the
hypothalamus (Figure 3f).
Further regions of increased post-surgical rCBF (Table 2) were
identified in addition to those specified a priori. In the frontal lobe,
clusters were identified in superior, middle, medial and orbital-
frontal cortices, in precentral gyrus and superior and inferior
parietal lobules bilaterally. In the temporal lobe, bilateral regions
of increased CBF were identified in superior, middle inferior
temporal and fusiform gyri, and in the lingual gyrus and precuneus
in the occipital lobe. In the basal ganglia, clusters were identified in
caudate and lentiform nuclei bilaterally. In the brainstem,
increased post-surgical CBF was identified bilaterally adjacent to
the lateral mid-pons, approximating to the trigeminal ganglion/
roots (Figure 4), with further continuous regions of increased rCBF
in mid-pons identified as principal sensory trigeminal nucleus (Vp),
extending posteriorly towards bilateral anterior cerebellar hemi-
spheres and vermis. Superior to Vp, a single cluster was observed
encompassing the pontine reticular formation, ascending superi-
orly into midbrain reticular formation including much of the
tegmentum including substantia nigra, ventral tegmental area and
red nucleus, and tectum including quadrigeminal body and
periaqueductal grey.
ROI Analysis: Temporal Variation Within Session
The anatomical location of each ROI, post-surgical CBF
change and associated time courses is illustrated in Figure 3(a2f).
Mixed effect model analyses in each a priori ROI demonstrated
that no significant variation in rCBF across scans (Time) was
identified within a single session. There were no other significant
second or third order interactions of Time with Hemisphere, or
Surgery, indicating that within-session temporal variation across
pCASL scans did not differ between cerebral hemispheres, either
in pre-surgical or post-surgical scanning sessions following either
left or right TME. In the light of these findings, assessment of
between session variation in rCBF was studied using ROIs derived
from set two, the average of all 6 cASL maps acquired within a
single session.
Pre/Post surgery differences
Mixed effect models were computed for all pain and control ROIs.
Main effects and interactions for ROIs are summarised in Table 3. In
each pain-related ROI, rCBF increases between 5210% were
identified following TME. Following correction for multiple compar-
isons, significant increases in post-surgical rCBF were observed in
AMY, HIP, SII, THAL, & INS ROIs, with strong trends in the same
direction identified in S1 and ACC, but not in control region V5/
MT. There was no effect of side of first tooth removal. Amain effect of
Hemisphere was observed in all ROIs, including control region V5/
MT but excluding HIP, which indicated that both pre- and post-
surgical rCBF values for ROIs were increased in right, compared to
left hemisphere. There were no significant interactions of Hemisphere
with Surgery side across all ROIs, meaning that surgery effects had
the same impact on each hemisphere independently of whether left or
right third molar was removed.
Relationships Between VAS Pain Estimates and rCBF
Within-subject correlation co-efficients (rw) were computed for
each ROI in each hemisphere to assess the relationship between
post-surgical pain rCBF and patients’ self-reported pain VAS
scores. Significant linear relationships were identified in AMY,
HIP, S1, SII, THAL, INS, PCC & ACC ROIs, (Table 4) but not
in control region V5/MT.
Discussion
Using pCASL, we have demonstrated reproducible, rCBF-
derived markers of ongoing, clinically-relevant pain. Increases in
rCBF were established following surgery, compared to pain-free
pre-surgical periods, in an un-biased voxel-wise analysis and in a
priori hypothesised regions inherent in the central processing of
pain, but not in control brain regions hypothesised to be
unchanged by pain. rCBF assessments were stable within a single
session and there were no between-session differences in post-
surgical rCBF following extraction of left, compared to right, teeth,
indicating a viable test-retest paradigm. Post-surgical CBF changes
correlated with VAS estimates of self-reported pain, but only in
brain regions known to underpin the processing of pain and not in
a control brain region. Quantitative changes in rCBF that
represent ongoing pain have potential as markers of treatment
efficacy for acute and persistent painful conditions.
Our findings of rCBF increases during pain following TME
provide valuable new insights into the representation of ongoing
post-surgical trigeminal pain. Independently of site of removal, the
pain resulting from tooth extraction is represented by a largely
bilateral pattern of rCBF changes throughout the brain. No
hemispheric differences in rCBF changes related to extraction
were found. These findings differ from earlier pain studies using
Figure 2. Post-surgical CBF changes in S1 relate to the classical
somatotopic representation of the jaw (adapted from [48]). CBF
increases coded in red illustrates mask image of clusters significant at
the p,0.05 (corrected) level. Yellow mask illustrates S1 ROI in left and
right cerebral hemispheres.
doi:10.1371/journal.pone.0017096.g002
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PET imaging, which have largely reported rCBF changes
contralateral to the painful body-site, for example, contralateral
increases in rCBF in PFC, insula cortex, and lentiform nucleus
were reported following a composite third molar extraction and
thermal heat pain challenge[16]. To the best of our knowledge,
this is the only other neuroimaging study of pain following third
molar extraction, but is difficult to relate to our findings due to the
confounding effect of a nociceptive heat stimulus applied to the
hand contralateral to the extracted tooth. Two recent reports using
experimental pain models have highlighted the potential of ASL in
Figure 3. (a–f) Time courses of post-surgical rCBF increases relating to pain in each a priori-defined ROI. Cluster-corrected (p,0.05) Z-
statistic map (red) indicates regional post-surgical increases in CBF relating to pain. In each row, a priori ROI masks are outlined in yellow. Plots at far
right of each row indicate time courses of post-surgical increases in CBF (ml/100 g/min) for each ROI extracted from each individual pCASL scan
(Red = left hemisphere, Blue = right hemisphere; Error bars represent 61 Standard Error).
doi:10.1371/journal.pone.0017096.g003
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pain research[29,30]. Several findings in those studies were
concordant with our own, namely, similar magnitude of CBF
values in grey matter and resulting rCBF changes in response to
pain in bilateral insula cortex, SII, cingulate cortex and
supplementary motor area, as well as responses in S1 and
thalamus. However, contrary to our own findings, responses to a
tonic painful hypertonic saline stimulus produced a CBF decrease
in S1, while several additional regions demonstrated a reduction
in magnitude of the CBF change over the time course of the
saline infusion. We speculate that such CBF decay characteristics
may relate to differences not only in physiological response but
also in terms of the threat value of an experimentally evoked
stimulus, compared to a genuine post-surgical tissue trauma
[20,49,50]. Differences in ASL implementation in those studies
precluded further examination of CBF changes inferior to the
thalamus and provided a lower spatial resolution than reported
here, and further comparisons are difficult due paradigm design,
body-site differences, and potentially confounding CBF changes
relating to patient introspection and movements derived from
providing VAS estimates of perceived pain throughout image
acquisition.
Our finding of bilateral post-surgical rCBF increases in S1 is
supported by primate electrophysiological studies of S1 neurones
with bilateral receptive fields[51], and other imaging reports of
evoked painful and non-painful stimulation of the trigeminal
nerve, e.g.[49,52]. Our observations of bilateral rCBF changes in
thalamus most likely relate particularly to representation of pain
by the trigeminal system. In particular, crossed and uncrossed
somatosensory and nociceptive afferents project from the trigem-
inal ganglion, via the principal sensory nucleus and nucleus
caudalis respectively, terminating at the ventral medial and lateral
posterior regions of the thalamus. Both these thalamic regions
contain bilateral representations of the intra-oral cavity[53]. In
addition, extensive interconnections in thalamus and hypothala-
Table 2. Additional regions of increased post-surgical CBF not specified a priori to underpin central processing of pain.
Structure Left Hemisphere Right Hemisphere
Z-stat x y z Z-stat x y z
Medial Frontal Gyrus 2.66 212 38 24 2.71 8 28 60
Superior Frontal Gyrus 2.74 220 24 68 2.91 34 56 28
Middle Frontal Gyrus 3.12 234 2 66 2.78 24 22 46
Inferior Frontal Gyrus 3.77 236 8 216 3.2 42 32 212
Orbital Gyrus - - - - 2.95 4 42 222
Rectal Gyrus - - - - 2.95 12 42 218
Rectal Gyrus - - - - 2.86 6 32 224
Precentral Gyrus 3.92 260 10 0 3.49 64 8 10
Postcentral Gyrus 2.7 228 248 72 3.22 22 234 66
Paracentral Lobule 3.46 10 232 62 3.15 6 242 72
Superior Parietal Lobule 2.92 222 260 56 3.2 26 266 56
Inferior Parietal Lobule 2.64 22 294 26 3.35 24 262 30
Superior Temporal Gyrus 3.78 264 26 4 3.77 36 8 220
Middle Temporal Gyrus - - - - 3.25 64 240 210
Inferior Temporal Gyrus - - - - 3.49 38 26 228
Fusiform Gyrus 3.32 236 234 222 3.61 36 240 218
Supramarginal Gyrus - - - - 2.84 228 246 38
Superior Occipital Gyrus - - - - 2.74 34 288 22
Precuneus 3.22 218 262 30 3.42 22 286 42
Lingual Gyrus 2.68 220 278 24 3.69 18 284 26
Cuneus 3.17 214 274 16 3.01 0 2100 4
Lentiform Nucleus 4.55 226 2 24 4.24 30 212 2
Caudate 3.78 210 20 6 4.71 6 4 2
Internal Capsule 4.26 218 20 26 4.49 30 6 24
Claustrum - - - - 4.31 32 0 8
Midbrain 3.22 216 222 28 3.54 4 224 214
Trigeminal System 3.53 218 218 232 - - - -
Pons 2.98 218 228 232 3.11 14 230 226
Cerebellum 3.25 220 246 232 3.23 12 256 226
Cerebellar Lingual - - - - 3.9 2 246 224
Declive - - - - 3.29 50 250 226
Culmen 3.2 212 270 212 3.68 12 244 224
doi:10.1371/journal.pone.0017096.t002
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mus[8] are likely to underpin bilateral changes in post-surgical
thalamic rCBF and may represent changes in arousal as well as the
experience of ongoing pain[54].
Demonstration of local increases in CBF in Vp during post-
surgical, ongoing trigeminal pain echo recent reports of changes in
brain activation in Vp in preclinical studies[55], following
hypertonic saline injection to the masseter muscle[56] and
following noxious electrical stimulation of the tooth pulp[49].
These findings challenge the traditional belief that Vp is associated
only with somatosensation, with nociceptive trigeminal afferents
processed only via nucleus caudalis of the trigeminal nerve[53]
and provide evidence that Vp plays a role in pain processing. We
could not identify rCBF changes in trigeminal nucleus caudalis;
this region of hindbrain was inferior to the ASL imaging volume
prescribed. Further methodological development is required to
include these regions within the imaging volume. We speculate
that extended brainstem coverage is likely to improve our ability to
detect significant bilateral post-surgical CBF increases in the
trigeminal ganglion (TG). While we report a cluster of significant
CBF increase in left TG only, CBF increases in right TG were
slightly below statistical cluster threshold and are likely to be
explained by type-II error. Our findings of CBF changes in
response to pain in the mandibular branch of TG are contrary to a
recent report using BOLD-fMRI, which reported signal changes
in the maxillary branch of TG only[49].
Taken together, our findings have potential to impact positively
upon the role of neuroimaging in assessing novel treatments for
pain[57]. We conjecture that in future, pCASL-derived rCBF
measures might be used as prospective independent endpoints for
pain assessment, rather than an adjunct to patient self-reported
pain. We acknowledge such a statement is likely to provoke
considerable controversy within the field[58]. In common with
previous reports, for example [59], our findings of correlations
between post-surgical rCBF and VAS estimates of self-reported
pain, limited only to brain regions known to underpin the pain
experience, demonstrate that our results are physiologically
plausible and relate (at least in part) to the pain experience.
Caution should be exercised, however, in over-interpretation of
VAS pain-estimate relationships with individual ROIs; first, given
the multi-dimensional nature of the pain experience [60]
multivariate regression analyses are likely to provide better
predictions of verbal response[61]; secondly, seeking only to
Figure 4. Anatomical and Functional Localisation of the Trigeminal Ganglion. (left) High resolution axial T2-weighted image illustrates
Meckel’s cave (magenta), the anatomical location of the trigeminal ganglion. (right) Post-surgical rCBF increases in trigeminal ganglion.
doi:10.1371/journal.pone.0017096.g004
Table 3. ROI Analysis summary table.
ROI Estimated Marginal Means
Pre-surgery v
Post-surgery Post-surgery (LvR) Hemisphere Session-Pair
Presurgery
Post-surgery
[L]
Post-surgery
[R]
Mean
difference F-ratio p
Mean
difference F-ratio p F-ratio p F-ratio p
AMY 56.6 60.2 61.3 4.2 14.45 0.000* 1.1 0.47 0.49 18.87 0.00 0.04 0.85
HIP 59.3 62.1 63.4 3.5 10.47 0.002* 1.3 0.73 0.40 0.57 0.45 0.08 0.78
INS 81.0 85.4 87.5 5.4 10.38 0.002* 2.1 0.79 0.38 27.23 0.00 0.00 0.99
S1 66.6 71.2 71.2 4.6 5.28 0.026 0 0.00 0.99 69.58 0.00 0.01 0.91
S2 71.9 76.2 77.2 4.8 11.02 0.002* 1.1 0.27 0.61 32.05 0.00 0.04 0.85
ACC 93.3 97.0 100.2 5.3 6.80 0.012 3.2 1.27 0.27 157.04 0.00 0.12 0.73
THAL 67.4 71.5 74.2 5.5 15.35 0.000* 2.8 1.98 0.17 18.34 0.00 0.03 0.85
V5 76.4 77.3 77.9 1.2 0.39 0.534 0.6 0.04 0.84 159.98 0.00 0.01 0.91
(Columns, left to right) ROI; Mean rCBF values from pre- and post-surgical sessions on left [L] and right [R] teeth; Mean rCBF difference between pre and post-surgical
sessions; F-statistic and associated p-value for main effect of Surgery (ROIs significant after Bonferroni correction illustrated by an asterisk); comparison of rCBF
differences between post-surgical sessions following left and right TME and associated F-statistic and p-value; F-statistic and associated p-value for rCBF differences
between left and right cerebral hemispheres.
doi:10.1371/journal.pone.0017096.t003
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replicate patient-self reported endpoints using neuroimaging
obviates its use. Arguably imaging-based markers of ongoing pain
should be considered in terms of their ability to add value over and
above self-report[57].
Our finding of reproducible rCBF data, within and between
sessions, makes ‘cross-over’ assessments of pain treatments tenable.
A critical next step to develop ASL as a methodology for assessing
modulation of ongoing pain will be to demonstrate pain-related
CBF changes that are attenuated by an analgesic of known
efficacy. Successful demonstration of analgesic-modulated CBF
changes should provide the evidence necessary to refine decision-
making techniques for assessing efficacy of novel interventions. We
envisage several potential uses for the pCASL methodology[57];
central effects of pain medications unrelated to their analgesic
action could be assessed in pain-free participants[62]; putative
mechanisms of action for novel analgesics might be investigated
and possible new indications for existing compounds in related
therapeutic areas uncovered; examinations of differential efficacy
across pharmacological classes and doses could be realistic
applications. In addition, availability of ASL in preclinical MRI
should facilitate translational research; ASL studies might
potentially illustrate new insights in ongoing pain in preclinical
cohorts in which examination of simple behavioural endpoints in
response to evoked pain has predominated to date [63].
Improved knowledge of acute ongoing pain should impact upon
understanding the central representation of chronic pain; bridging
this gap might facilitate developing new medications for
intractable pain conditions that are often resistant to currently
approved analgesics[64]. Given increasing evidence for changes in
brain function and structure relating to chronicity of pain[12], a
better understanding of disease-specific ‘neurosignatures’ will be
imperative. The ROI-based methodology described here is
appropriate to examining post-surgical pain in healthy volunteers,
but cannot be applied universally to all persistent pain states;
instead, selecting a set of a priori ROIs based on previous
knowledge of the specific pain condition should be preferred.
While we believe ASL has utility in analgesic trials, the method
should be equally applicable to assessing changes in ongoing pain
in other, non-pharmaceutical scenarios; for example, pain
modulation following cognitive behavioural therapy[65]. Addi-
tional applications might include assessing pain in individuals less
able to verbalise self-reported pain, for example children[66] or
potentially, patients with consciousness disorders[67].
In summary, using perfusion MRI, in concert with the TME
model, we have described a network of rCBF increases representing
ongoing post-surgical pain. Post-surgical CBF changes are repro-
ducible within- and between sessions. Our findings represent the
beginning of a novel approach to measure ongoing pain as an
alternative to self-report. The approach is stable and provides
robust, repeatable results in a relatively small group of participants,
compared to conventional studies solely using self-reported pain as
endpoints[68]. Reduction in study numbers is likely to provide
benefits in the early phase assessment of putative analgesics and
other interventions, both in terms of cost and time. While we have
focussed upon assessment of acute, ongoing post-surgical pain, we
believe that developing the methodology for examining pain in
patients with persistent painful conditions will be valuable for
pioneering much-needed new therapies.
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